findmyKOL

John Bilezikian, MD

Enriched profile

Silberberg Professor of Medicine, Vagelos College of Physicians and Surgeons, Columbia University · Vagelos College of Physicians and Surgeons

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusBone health and osteoporosis research+4
Active KOLfindmyKOL type: EliteLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021–2025NIH funding1985–2024Why? →

John Bilezikian is Silberberg Professor of Medicine, Vagelos College of Physicians and Surgeons, Columbia University at Vagelos College of Physicians and Surgeons. OpenAlex indexes 896 publications with 76,781 citations (h-index 138); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 18 Oct 2026

Overview

Updated 21 Oct 2026

John Bilezikian, M.D., is Silberberg Professor of Medicine, Vagelos College of Physicians and Surgeons, Columbia University. The public record shows 896 publications with 76,781 citations (h-index 138), centered on Bone health and osteoporosis research, Parathyroid Disorders and Treatments, Thyroid and Parathyroid Surgery. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 14 companies, 23 NIH-funded awards (1985–2024).

  • Top research focus: Bone health and osteoporosis research
  • 9 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Osteoporosis4 trialsHypoparathyroidism3 trialsHyperparathyroidism2 trialsHyperparathyroidism, Primary2 trialsBone Diseases, Metabolic1 trialBone Diseases1 trialVitamin D Deficiency1 trial

Research focus

OpenAlex concept fingerprint
Bone health and osteoporosis researchParathyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryBone Metabolism and DiseasesVitamin D Research Studies

Drugs & molecules

across trials, industry payments and publications
Evenitygeneric · RomosozumabClinical trials—Industry payments260Publications—Proliageneric · DenosumabClinical trials—Industry payments60Publications—Tymlosgeneric · AbaloparatideClinical trials—Industry payments52Publications—Yorvipathgeneric · TeriparatideClinical trials—Industry payments18Publications—Skytrofageneric · LonapegsomatropinClinical trials—Industry payments16Publications—NATPARAClinical trials—Industry payments10Publications—Strensiqgeneric · Asfotase alfaClinical trials—Industry payments6Publications—Aimoviggeneric · ErenumabClinical trials—Industry payments1Publications—Iqirvogeneric · ElafibranorClinical trials—Industry payments1Publications—Pyrukyndgeneric · MitapivatClinical trials—Industry payments1Publications—Synthroidgeneric · LevothyroxineClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Amgen Inc.Clinical trials—Industry payments320Ascendis Pharma IncClinical trials—Industry payments130Radius Health, Inc.Clinical trials—Industry payments60Ascendis Pharma Endocrinology IncClinical trials—Industry payments16Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments14Merck Sharp & Dohme LLCClinical trials—Industry payments7Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments6Columbia UniversityClinical trials6Industry payments—Ipsen InnovationClinical trials—Industry payments3Novo Nordisk Health Care AGClinical trials—Industry payments3Abbvie Inc.Clinical trials—Industry payments1Agios Pharmaceuticals, Inc.Clinical trials—Industry payments1John P. BilezikianClinical trials1Industry payments—National Center for Complementary and Integrative Health (NCCIH)Clinical trials1Industry payments—National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Clinical trials1Industry payments—Novo Nordisk IncClinical trials—Industry payments1Ultragenyx Pharmaceutical Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
896publications

Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.

76,781citations

Total citations across indexed works.

138h-index

Hirsch index (OpenAlex). i10-index 548.

Clinical & industry

trials, payments and federal funding
9clinical trials

Investigator role on registered studies.

View trials ↓
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
23NIH grants · 1985–2024

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 21 Oct 2026

Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 21 Oct 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    50.3%
    Parathyroid Hormone Analog29%
    Teriparatide64%Forteo36%
    Part D<11 patients
    l-Thyroxine21.3%
    Synthroid64%Levothyroxine Sodium36%
    Part D<11 patients
  • Musculoskeletal

    41.9%
    RANK Ligand Inhibitor24.5%
    Prolia100%
    Part D≥22 patients
    Bisphosphonates17.4%
    Risedronate Sodium100%
    Part D<11 patients
  • Genitourinary & hormones

    7.7%
    Estrogen Agonist/Antagonist7.7%
    Raloxifene Hcl100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 21 Oct 2026

23 NIH research awards on record, funded 1985–2024 per NIH RePORTER. The latest:

Congress activity

Updated 21 Oct 2026

4 congress contributions (2018–2025) across AACE, ENDO per OpenAlex. The most recent:

Publications

Network

Updated 21 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Shonni J. Silverberg124Mishaela Ruth Rubin96Natalie Elissa Cusano87Elizabeth J. Shane66Edward Michael Lewiecki64David W. Dempster48Michael Mannstadt47Bart Lyman Clarke43Neil Binkley43Aliya Aziz Khan41Donald J. McMahon39Barbara Campolina Carvalho Silva39Paul D. Miller39John T. Jr. Potts38Clifford james Rosen37Dolores Shoback36Stephen A. Morris35Claudio Marcocci35Roger Bouillon33Aline G. Costa33Nelson B. Watts31Marcella Donovan Walker28Maria Luisa Brandi28Gaia Tabacco27Lars Rejnmark27Tamara Vokes27Michael R. McClung26Lorraine A. Fitzpatrick26Francisco Alfredo Farias Bandeira25Peter Robert Ebeling23Marise Lazaretti‐Castro23Gordon Henry Guyatt22Robert A. Adler22Ethel S. Siris22Felicia Cosman21Andrea Giustina21Michael A. Levine21René Rizzoli21Donovan Tay20Munro Peacock20

Online presence

Updated 21 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/john-bilezikian-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    vagelos.columbia.edu/profile/john-p-bilezikian-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 21 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Medical Advisor

    Hypoparathyroidism Association

    2006
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
  • President

    International Society of Clinical Densitometry

    2001
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.iscd.org ↗
  • President

    American Society of Bone and Mineral Research

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
  • Chair

    Endocrine Fellows Foundation

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
  • Chief Emeritus

    Division of Endocrinology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.